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Abstract.  Class I  major histocompatibility (MHC) an- 
tigens are expressed by virtually all mammalian cells, 
yet their levels of expression and behavior on the cell 
surface vary in a cell-specific fashion. A  panel of lym- 
phoid (both B and T) and nonlymphoid cell lines was 
used to study the kinetics of internalization of the 
H-2L  d class I MHC in different cell types. These 
studies revealed that endocytosis of H-2L  J occurs by 
both constitutive and PMA-regulated pathways in lym- 
phoid cells, but only by a  PMA-refractory pathway in 
the nonlymphoid cells tested. Transfectant derivatives 
of the T  lymphoma, EL4, which express wild-type or 
mutant H-2L  d class I  MHC antigens, were used to in- 
vestigate the requirement for the cytoplasmic domain 
of the class I  MHC antigen for its endocytosis in T 
lymphocytes. These studies showed that modification 
or deletion of the cytoplasmic domain of H-2L  ~ abro- 
gates endocytosis via a  PMA-regulated pathway. The 
role of cytoplasmic domain phosphorylation in PMA- 
inducible endocytosis was examined. The wild-type 
H-2L  d antigen is phosphorylated in all cell types ex- 
amined, and this phosphorylation is up-regulated by 
PMA treatment.  In contrast, cytoplasmic domain mu- 
tants of H-2L  d fail to be phosphorylated in vivo, in the 
presence or absence of PMA.  The universality of 
PMA-inducible hyperphosphorylation of the class I 
MHC antigen among diverse cell types leads us to 
conclude that phosphorylation of the cytoplasmic do- 
main, while perhaps  necessary, is not sufficient for 
triggering endocytosis via a  PMA-inducible pathway. 
Furthermore, the results with the cytoplasmic domain 
mutants of H-2L  ° suggest that a  structural conforma- 
tion of the class I MHC cytoplasmic domain is re- 
quired for endocytosis via this route. 
C 
LASS I major histocompatibility (MHC)' antigens are 
integral membrane glycoproteins which occur at vary- 
ing levels on the surfaces of all mammalian somatic 
cells. Lymphoid cells are a particularly  rich source of class I 
MHC antigens, a  striking fact in  the face of the ascribed 
function of the MHC molecule as a membrane-bound ligand 
for the T cell receptor for antigen. In this well-documented 
role, the MHC molecule on a target cell surface "presents" 
foreign antigen peptides to the T cell receptor that is specific 
for both the foreign antigen and the MHC molecule (Zinker- 
nagel and Doherty,  1979;  Bjorkman et al.,  1987a,b).  The 
target cell in this situation need not be a lymphoid cell, but 
can be any cell in the body which bears the foreign antigen. 
The class I MHC molecule has been shown to possess, on 
its external face distal to the membrane, a putative peptide 
binding groove which has been shown to interact with for- 
eign antigenic peptides (Bjorkman et al., 1987b). The amino 
acids which compose this groove have been shown in func- 
tional studies to bind to antigenic peptides (Townsend et al., 
1. Abbreviations used in this paper:/32-M,/3~-microglobulin;  MHC, major 
histocompatibility (antigen). 
1986). Interestingly, these antigen-associated amino acids do 
not bind the entire antigen, but can bind proteolytic frag- 
ments of the antigen or oligopeptides 11-16 amino acids in 
length that are identical to regions of that antigen (Townsend 
et al.,  1986).  Moreover, treatment of cells with agents that 
render them unable to acidify the low pH vesicles involved 
in proteolysis renders these cells unable to present antigen 
(Unanue,  1984).  This has led to the widely held belief that 
antigens must be processed or degraded before association 
with MHC molecules, and that this association most likely 
occurs in an as yet unidentified cytoplasmic vesicle through 
which both the antigenic peptide and the class I MHC anti- 
gen must pass en route to the cell surface (Morrison et al., 
1986; Germain, 1986, 1988; Yewdell et al.,  1987).  Hence, 
the intracellular routing of MHC antigens is likely to be of 
paramount importance  in  their role as  antigen-presenting 
molecules. 
We are interested in the cell biology of class I MHC glyco- 
proteins, with the specific goal of determining the role of the 
intracellular transport of these molecules in their functions 
as immune effector molecules. Our interest derives from sev- 
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gens. The first of these is the apparent heterogeneity in the 
trafficking of these proteins in different cell types: class I 
MHC molecules have been shown to be internalized rapidly 
by T lymphocytes  which have been activated by mitogens and 
T lymphomas, but not by B lymphocytes, B lymphomas, or 
L  cell fibroblasts (Machy et al.,  1982a,b,  1987; Tse and 
Pernis, 1984; Pernis, 1985; Aragnol et al., 1986). Endocyto- 
sis of class I MHC molecules also has been observed in mac- 
rophage/monocyte cells (Dasgupta et al.,  1988).  The endo- 
cytosed class I molecules in T cells and monocytes enter the 
cell via coated pits (Machy et al.,  1987; Dasgupta et al., 
1988), in contrast to antibody cross-linked class I MHC anti- 
gens  internalized by fibroblasts (Huet et al.,  1980).  This 
differential internalization of class  I  MHC  molecules by 
different cell types is striking, since biosynthetic studies have 
shown that the intracellular routing during biosynthesis is 
relatively invariant among cell types (Krangel et al.,  1979; 
Dobberstein et al.,  1979;  Owen et al.,  1980;  Sege et al., 
1981; Ztifiiga and Hood,  1986).  Another notable feature of 
class I MHC antigens is that their cytoplasmic domains are 
phosphorylated in vivo, and this phosphorylation is up-reg- 
ulated by treatment of cells with phorbol esters (McCluskey 
et al.,  1986).  The phosphorylation of the cytoplasmic do- 
main and its modulation by phorbol esters suggest a regula- 
tion of cell surface expression of class I MHC antigens akin 
to that described for other cell surface proteins, such as the 
transferrin and epidermal growth factor receptors (Davis and 
Czech,  1984;  Hunter et al.,  1984;  Klausner et al.,  1984; 
Hanover and Dickson, 1985; May et al., 1984,  1985; Begui- 
not et al., 1985). Thus, the regulation of differential endocy- 
tosis of class I MHC antigens in different cell types may play 
a pivotal  role in their function as immunoregulatory mole- 
cules. We are interested in identifying structural features of 
the class I MHC molecule which may be required for appro- 
priate intracellular routing, with the ultimate goal of using 
transport-defective mutant molecules to study the functional 
significance of this process. Since the endocytosis of a num- 
ber of cell surface receptors (e.g., low density lipoprotein, 
epidermal growth factor, transferrin, and poly-Ig receptors) 
is abrogated by mutations in the cytoplasmic domains (Gold- 
stein et al., 1985; Lehrman et al., 1985; Davis et al., 1986, 
1987; Prywes et al., 1986; Rothenberger et al., 1987; Iaco- 
petta et al., 1988; Mostov et al., 1986), we set out to explore 
the  role of the cytoplasmic tail  in the  endocytosis of the 
class I MHC molecule. 
In this paper we report results from studies on the H-2L  d 
class I MHC antigen in a number of lymphoid and nonlym- 
phoid cell lines.  The data presented here suggest that in- 
ternalization of class I  MHC antigens occurs by both un- 
regulated  and  phorbol  ester-regulated  pathways  and  that 
internalization by the latter pathway is a lymphoid cell-spe- 
cific phenomenon. Studies with transfectant cell lines gener- 
ated from the T  lymphoma, EL4, which express  in vitro 
mutagenesis-derived mutant forms of the H-2L  d gene, show 
that structural information contained within the cytoplasmic 
domain of the class I MHC glycoprotein is required for en- 
docytosis via both constitutive and phorbol ester-regulated 
pathways.  Furthermore, while cytoplasmic domain mutants 
of the  H-2L  ~ antigen are  neither phosphorylated nor en- 
docytosed in PMA-treated cells, there is not a direct correla- 
tion between PMA-induced phosphorylation of the H-2L  ~ 
class I MHC antigen and PMA-induced endocytosis in that 
PMA-induced hyperphosphorylation of class I MHC mole- 
cules occurs in all cell types examined. 
Materials and Methods 
Reagents 
PMA  was  purchased  from  Calbiochem-Behring Corp.  (La  Jolla,  CA); 
[J~S]methionine,  [~2P]orthophosphate,  and 12SIodine were purchased from 
New England Nuclear (Boston, MA);  DME and RPMI  1640  were pur- 
chased form Mediatech (Washington, DC); FCS and Serum Plus were from 
Hazelton Research Products (Lenexa, KS); G418  sulfate (Geneticin) was 
from Gibco Laboratories (Grand Island, NY); RIA grade BSA, hypoxan- 
thine, aminopterin, and thymidine were obtained from Sigma Chemical Co. 
(St.  Louis, MO);  Enzymobeads were from Bio-Rad Laboratories (Rich- 
mond, CA); and Sephadex G-50 and protein A-Sepharose were from Phar- 
macia Fine Chemicals (Piscataway,  NJ). 
Cell Lines 
The cell lines used in these studies are described in Table I. P815, ELA, and 
the EIA transfectants were grown in DME supplemented with 10% Serum 
Plus and 40/zg/ml G418;  18-48 and BCL1 cells were grown in RPM1  1640 
supplemented with  10%  FCS, 5  ×  10  -5  M  B-mereaptoethanol, and 40 
p,g/ml G418; and 27.5.27 D1 cells were maintained in DME supplemented 
with  10%  FCS and HAT (hypoxanthine, aminopterin, thymidine) as de- 
scribed previously (Zdfiiga  et al.,  1983). 
H-2L  d Gene Constructs and Transfection of 
Fibroblasts and EL4 Cells 
In vitro mutagenesis and characterization of mutant H-2L  d gene constructs 
encoding the BAL907 and 2.2.1  H-2L  d molecules (Fig.  1) are described in 
previous  publications  (Ztifiiga  et  al.,  1983;  Zdfiiga  and  Hood,  1986). 
Mouse L cell transfectants expressing the wild-type H-2L  d gene were de- 
scribed previously (Ztifiiga et al.,  1983).  For transfection of EL4 T  lym- 
phoma cells, the cloned DNAs bearing wild-type and mutant gene con- 
structs were further modified by the inclusion of a small casette containing 
the neomycin resistance gene driven off of an early SV-40 promoter. These 
constructs were made by Scott E  Walk (University of Virginia School of 
Medicine, Charlottesville, VA). These constructs were introduced into EL4 
lymphoma cells by protoplast fusion (Sandri-Goldin et al., 1981), and stable 
transformants were selected in RPMI 1640 supplemented with 5% FCS and 
400 ~tg/ml G418 sulfate (Geneticin). Transfectant EL4 cell lines were gener- 
ated and cloned by Dr. Mark Holterman (University of Virginia School of 
Medicine, Charlottesville, VA). 
Purification and Iodination of  Antibodies 
The 30.5.7 and 28.14.8  mAbs were purified from culture supernatants by 
affinity chromatography over protein A-Sepharose equilibrated with 3 M 
NaCl, 1.5 M glycine, and 0.0025 M sodium azide, pH 8.9. Antibodies were 
eluted with 0.1 M sodium citrate, pH 5.0. Antibodies were dialyzed against 
0.01 M sodium phosphate, pH 6.2, and then radioiodinated with the solid- 
phase Enzymobead reagent (Bio-Rad Laboratories), according to the manu- 
facturer's instructions. Briefly,  100 ~tg of antibody which had been purified 
by affinity chromatography on protein A-Sepharose were radioiodinated in 
a cocktail containing I mCi ~25Iodine, 0.33% glucose, and 50 ~1 Bio-Rad 
Laboratories Enzymobead reagent in 0.04 M sodium phosphate buffer, pH 
7.5, in a final volume of 150/xl at room temperature for 15 min. At the end 
of the  incubation  period  the  sample was  centrifuged in  an  Eppendorf 
microfuge (Brinkman Instruments Co., Westbury,  NY) for 7 min at 1,500 
rpm, and the radioiodinated mAb was separated from unincorporated iso- 
tope by gel filtration over a  2-ml column of Sephadex G-50 which was 
equilibrated with 0.2 M sodium phosphate buffer,  pH 7.5, and which had 
been preloaded with 20 mg BSA. Preloading was achieved by washing the 
column with 4 ml of 5 mg/ml of BSA in 0.2 M sodium phosphate buffer, 
pH 7.5, followed by 2 ml of 0.2 M sodium phosphate buffer,  pH 7.5. 
Cell Surface RIA 
Cells were washed in PBS, resuspended to l07 cells/ml in PBS/FCS/azide 
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×  105 cells/well  in round-bottomed,  96-well plates (Dynatech lmmulon 
Corp., Alexandria, VA),  and were incubated at 4°C for  1 h  with varying 
amounts of 125I-labeled  mAb as  indicated  in Fig.  2.  Cells were  washed 
three times in PBS/FCS/azide, and cell pellets were resuspended in 100/~1 
PBS before quantitation of radioactivity bound in the Beckman Instruments 
Inc. (Fullerton, CA) model 7000 gamma conmer. 
Endocytosis Assay 
The general scheme for the endocytosis assay is illustrated in Fig. 3. Cells 
were washed in PBS, resuspended to  107 cells/ml in PBS/FCS (PBS sup- 
plemented with 0.2%  FCS),  plated at 5  ×  10  ~ cells/well  in round-bot- 
tomed, 96-well plates (Dynatech Immulon Corp.), and incubated at 4°C for 
l  h with 5  ×  l0  s cpm ~25I-labeled mAb in a final volume of 50 #l. Cells 
were washed three times with PBS/FCS,  Pellets were incubated in 50 ~1 
DME in the presence or absence of PMA at 37°C in a CO2 incubator for 
the time periods indicated in Figs. 5 and 6. At the end of each incubation 
period cells were diluted with  100/~1 PBS/BSA/azide (PBS supplemented 
with 2 mg/ml BSA and 5 mM sodium azide), centrifuged, and the superna- 
tams were harvested. Cell pellets were resuspended in 50 ~tl PBS and in- 
cubated for 10 min at 4°C with 150/zl ice-cold barbital buffer (20 mM so- 
dium barbital, 28 mM sodium acetate,  114 mM sodium chloride, pH 3). 
The cells were centrifuged, resuspended in 150/~1 barbital buffer, and cen- 
trifuged immediately. The barbital washes were pooled. Quantitation of an- 
tibody shed during the 37°C incubation, antibody stripped from the cell sur- 
face by barbital,  and antibody internalized was achieved by counting the 
post-37°C supernatant, the barbital  washes, ahd the cell  pellets,  respec- 
tively, in a  Beckman Instruments, Inc. model 7000 gamma counter. 
In Vivo  Labeling of Cells and lmmunoprecipitation 
of  H-2 Polypeptides 
Cells were washed three times in PBS or phosphate-free buRi~r (0.15  M 
NaC|, 0.01  M  MgC[2,  2  mM gIutamine,  t.8 mM g/,ucose, 0,0t  M  Tris- 
acetate,  pH  7.4)  for  [35S]methionine and  [32p]orthophosphate  labeling, 
respectively, and then resuspended at a concentration of 107 cells/ml in la- 
beling medium. In some experiments the cells were labeled with [35Slme- 
thionine and  [32P]orthophosphate separately,  in which case the labeling 
media were methionine-deficient RPMI 1640 (lrvine Scientific, Santa Ana, 
CA) supplemented with  10%  dialyzed FCS,  and phosphate-free medium 
(prepared according to Gibco Laboratories formulations for RPMI  1640, 
except that the medium was buffered with Hepes rather than with phosphate) 
supplemented with 9  mg/ml BSA, respectively. In other studies, [3SSlme- 
thionine and [32p]orthophosphate labeling were carried out on the same 
cell  sample simultaneously, in  which  case  Hepes-buffered RPMI  1640 
which was deficient in both methionine and phosphate and was supple- 
mented with 9 mg/ml BSA was used. The cells were incubated for a mini- 
mum of 30 rain at 37°C in a CO2 incubator before the addition of labeled 
precursor. For biosynthetic labeling of proteins, [35Slmethionine  was added 
to cells in methionine-deficient RPMI 1640 to a final concentration of 300 
/xCi/ml, and ceils were incubated for 2-3 h at 37°C in a CO2 incubator. For 
phosphate labeling of cells, carrier-free [a2p]orthophosphate was added to 
cells in phosphate-free medium to a  final concentration of 1 mCi/ml, and 
cells were incubated for 2  h  at 37°C in a  CO2 incubator. For studies on 
the induction of phosphorylation by phorbol esters, PMA was added to a 
final concentration of 10 ng/ml or 50 ng/ml, and the cells were incubated 
an additional 30 min. 
At the end of the labeling period, ceils were washed twice with PBS sup- 
plemented with phosphatase inhibitors (0.4 mM EDTA, t0 mM NaF, 10 mM 
sodium pyrophosphate, 0.4 mM sodium vanadate), and lysed at  107 cells/ 
m¿_ The lysis buffer consisted of the phosphatase inhibitors (above), 1 raM 
PMSE 0.15 M NaCI, 0.05 M Tris-HCl, pH Z3, and 0.5% Triton X-100, To 
each lysate an adjusting buffer (to bring the final concentration of the lysis 
buffer to 0.9% Triton X-100 and 5 mM EDTA, while maintaining the con- 
centrations of the other reagents), 25/xl of a 50% slurry of protein A-Sepha- 
rose in lysis buffer, and 5 #1 of a  10%  solution of normal mouse serum in 
lysis buffer were added. This suspension was then rocked at 4°C for >2 h, 
and then the protein A-Sepharose was removed by  centrifugation.  This 
preclear was repeated twice for each sample (to preclear any labeled mole- 
cules which bound nonspecifically to the protein A-Sepharose or the normal 
mouse serum immunoglobulins). After the last preclear, 25/~1 of the protein 
A-Sepharose slurry and 3.6-7.2/zg 30.5.7  mAb were added to each lysate, 
and the suspension was rocked at 4~C for al least 2 h. The protein A-Sepha- 
rose was washed three times at 4°C with 1 ml of wash buffer I (0.1% Triton 
Table L Mouse Lymphoid and Nonlymphoid Cell Lines 
Used in this Study 
Cell line  Cell  type  H-2 protein studied 
18-48  pre-B  H-2L  d 
BCL1  B  H-2L  d 
ELI  T  lymphoma  H-2D  ~ 
ELO3  T  lymphoma  H-2D  b,  transfected H-2L  d 
El.A,.907  T  lymphoma  H-2D  b,  transfected H-2L  d (BAL 907) 
EL4.2.2.1  T  lymphoma  H-2D  b,  transfected H-2L  d (2.2,1) 
P815  Mastocytoma  H-2L  d 
27.5.27  Di  Fibroblast  Transfected H-2L  d 
The 18--48, BCL1, and P815 cell lines are all of the d haplotype and therefore 
naturally express the H-2L  ° class I  MHC molecule. The ELd3 and 27.5.27 
DI cell lines were derived by transfection of the ELA T lymphoma (b haplo- 
type) and L cells (k haplotype)  with the wild-type H-2L  d gene as described in 
Materials and Methods and Ztifiiga el al. (1983).  The EIA.907 and EL4.2.2.1 
cell lines were derived by transfection of EIA cells with the BAL 907 and 2.2.1 
mutants of  H-2L  d,  respectively  (Fig.  1),  as  described  in  Materials  and 
Methods. 
X-100, 0.02% SDS, 0.15 M NaC[, 0.05 M Tris-HCI, pH 7.5, 5 mM EDTA, 
I mM PMSF, and phosphatase inhibitors), then one time at 4°C with 1 mt 
wash buffer I1 (0.15 M NaCI, 0.05 M Tris-HCl, pH 7.5, 5 mM EDTA, 1 mM 
PMSF, and phosphatase inhibitors). H-2 proteins were then eluted twice se- 
quentially at room temperature with 25  #1 of elution buffer (0.5%  SDS, 
0.01 M  DTT,  and 0.(31 M  Tris-HCl, pH 7.5).  Lysates from which H-2L  a 
had been removed by immunoprecipitation with the 30.5.7 mAb were subse- 
quently incubated with the 28.14.8 mAb to immunoprecipitate the H-2D  b 
protein,  Control experiments with cell lines which express H-2L  d b~t not 
H-2D  b show that no detectable H-2L  d remains after the 30.5.7 mAb immu- 
noprecipitation step.  l-/~l samples of eluates were added to 3 ml of Biofluor 
scintillation fluid, then counted. 
Polyacrylamide Gel Analysis of  H-2 Glycoproteins 
Immunoprecipitated proteins were analyzed by PAGE and autoradiography 
as described previously (Ztifiiga  and Hood,  1986).  Densitometry analysis 
was performed on the Bio-Rad Laboratories model 620 video densitometer. 
Quantitation was performed as described in Figs. 7 and 8. 
Results 
Cell Surface Expression of ~ld-type and Mutant 
H-2L d  A n tigens 
We examined the cell surface expression of the H-2L  d anti- 
gen in two B cell lines, three ELA T lymphoma transfectants, 
the P815 mastocytoma, and an L cell transfectant by RIA(Ta- 
ble I; Fig. 2). All of these cell lines, including EL4 transfec- 
rants expressing  mutant H-2L  d molecules  (Fig.  1) with an 
altered  (EL4.907)  or no (EL4.2.2.1)  cytoplasmic  tail,  ex- 
press this class I MHC molecule at comparable levels (Fig. 
2).  The cell surface expression of the mutant H-2L  d mole- 
cules expressed by EL4.907 and EIA.2.2.1 is not surprising, 
since we have observed previously that the cytoplasmic do- 
main of the H-2L  ~ antigen is not required for the cell sur- 
face expression of this glycoprotein by L cell fibroblasts, but 
that it facilitates its intracellular transport during biosynthe- 
sis (Zdfiiga and Hood,  1986).  Although the BAL 907 and 
2.2.1 mutant molecules occur at the cell surface at a density 
comparable to that of the H-2L  d glycoprotein which bears a 
full length cytoplasmic tail, it is worth noting that they are 
transported to the EL4 plasma membrane more slowly than 
is the wild-type molecule (Zffiiga, M. C., unpublished data). 
Hence, the cytoplasmic domain may be involved in seques- 
Capps el a}. Phosphorylation  and Endocytosis of Class 1 MHC  1319 wt H-2L  d 
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Figure 1. Cytoplasmic  tail sequences of wild-type and mutant H-2L  d mutants. The wild-type (wt) H-2L  d gene sequence is deduced  from 
the DNA sequence of a genomic clone determined by Moore et al. (1982). The BAL 907 mutant was generated by deletion mutagenesis 
and has been described previously (Zfifiiga et al., 1983). The 2.2.1 mutant of H-2L  d was made by site-directed mutagenesis (Ztifiiga and 
Hood,  1986). Cytoplasmic domain sequences were predicted from the DNA sequences published previously (Zdfiiga et al., 1983; Ztifiiga 
and Hood,  1986). The external domains of the H-2L  d antigens are depicted by the bold line, whereas/~2-M is represented by the hatched 
line. The membrane-spanning  regions of the H-2L  d glycoproteins  are depicted  by the helical  structures  embedded  in the phospholipid 
bilayer. 
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Figure 2.  Cell surface expression  of H-2L  d by lymphoid and nonlymphoid cell lines. The cell lines listed in Table 1 were tested for cell 
surface expression of the transfected H-2L  d gene product and the endogenous H-2D  b gene product by RIA as described  in Materials and 
Methods.  The 30.5.7 mAb (A and C) binds to H-2L  d, whereas the 28.14.8 mAb (B) binds both H-2L  d and H-2D  b (Ozato et ah,  1980; 
Evans et al., 1982). Hence, EL4 cells (e) which are of the b haplotype type bind 28.14.8 (B) but not 30.5.7 (A), in contrast to ELd3 cells 
(transfected with the wild-type H-2L  d gene; o) (B), EL4.907 cells (transfected  with the BAL-907-2 mutant of H-2Ld; e) and EL4.2.2.1 
cells (transfected with the 2.2.1 mutant of H-2Ld; r,), which bind both mAbs. BW5147 thymoma cells (H-2 k haplotype,  n) serve as a nega- 
tive control for the 28.14.8 mAb (B). C shows the binding of 30.5.7 by BCL1 (El), 18-48 (O), 27.5.27 DI (e), and P815 (e). Each data 
point represents  the average of duplicates,  and barring the exceptions listed below, is within 7% of the experimentally  obtained values. 
The data points that do not fall within this degree of precision are those for the EL4 cells incubated with 5  ×  105 cpm '251-30.5.7 (A), 
the EL4.2.2.1  cells incubated  with 2  x  104 cpm ~251-30.5.7 (A), the BW5147 cells incubated  with 2  ×  104 cpm and 5  ×  105 cpm of 
'251-28.14.8 (B), and the 27.5.27 D1 cells incubated with 2  ×  104 cpm and 5  ×  105 cpm '251-30.5.7 (C), for which the averages represented 
by the data points given differ from the experimentally  obtained values by 22.2,  12.0, 12.9,  11.3, 9.57, and 16.22%,  respectively. 
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Figure 3.  Schematic  presentation  of endocytosis assay. The  cell 
lines listed in Table I were incubated with  ~2sI-30.5.7 mAb or t251- 
28.14.8 mAb for 1 h at 4°C as described in Materials and Methods. 
The cells were washed and incubated at 37°C (or at 4°C in the case 
of control samples) in the presence or absence of PMA for varying 
periods of time and then subjected to a wash with acid barbital to 
strip antibody which is bound to the cell surface. Antibody which 
is resistant to acid stripping (over and beyond that which is bound 
in negative control samples) is assumed to have been internalized 
by the cells (Olefsky and Kao,  1982). Refer to the Materials and 
Methods and Results sections of text for further details of endocyto- 
sis assay. 
tering of class I MHC glycoproteins into intracellular trans- 
port  organelles,  both  during  exocytic  and  endocytic  pro- 
cesses (see below). 
Internalization of Class I MHC Antigens by Lymphoid 
Cells Is Up-Regulated by Treatment with 
Phorbol Esters 
Phorbol esters are potent activators of calcium, phospholipid- 
100" 
90 
80 
- 
"~  70" 
~  se 
$1 
~  50- 
E  3o 
m. 
-ff  le 
N  . 
u  a  i  i  i 
20  40  60  80  100 
ng/ml PMA 
Figure 4. Effect of PMA on internalization of H-2L  ~ by EL4 trans- 
fectants.  ELO3 cells,  which  were transfected  with  the  wild-type 
H-2L  d gene encoding the protein bearing the full length cytoplas- 
mic domain (Fig.  1), were incubated with 5 ×  105 cpm 12-~I-30.5.7 
mAb at 4°C for I  h,  and washed as described  in Materials  and 
Methods. Cells were then incubated at 37°C for 180 min in medium 
containing the indicated concentrations of PMA and processed as 
described  in Materials and Methods and Fig. 3.  Each point rep- 
resents the average of triplicates.  The increases in internalization 
of ~251-30.5.7 mAb relative  to the 0  ng/ml control  were 25%  at 
10 ng/ml PMA, 44% at 25 ng/ml PMA,  54% at 50 ng/ml PMA, 
and 62% at 100 ng/ml PMA. The SD of each data point shown is 
<3% from the given value, except for the data point for 10 ng/ml 
PMA which has an SD of 6.8% from the given value. 
dependent protein kinase C, and AMP-dependent protein ki- 
nase A  (Castagna et al.,  1982;  Nishizuka,  1984;  Berridge 
and Irvine, 1984). Phorbol esters have been used extensively 
in the analysis of receptor-mediated endocytosis. These com- 
pounds modulate the cell surface expression of transferrin 
and epidermal growth factor receptors by stimulating the ex- 
ocytic and/or  endocytic processes  (Klausner et al.,  1984; 
Hanover and  Dickson,  1985;  May et al.,  1985).  Phorbol 
ester treatment of erythroleukemia cells causes a rapid de- 
crease in cell surface transferrin receptor expression (Klaus- 
ner et al.,  1984), whereas the same treatment of the macro- 
phage cell line, J774,  results in higher levels of cell surface 
transferrin receptor expression (Buys et al., 1984). Thus, the 
effect of phorbol esters is cell line-specific, at least in the case 
of the transferrin receptor. These observations prompted us 
to  consider  the  possibility  that the previously  reported T 
cell-specific endocytosis of class I MHC antigens is modu- 
lated by phorbol esters. 
We examined the effects of the phorbol ester, PMA, on the 
internalization of endogenous and transfected class I MHC 
molecules by  lymphoid  and  nonlymphoid  cells  using  the 
modified RIA described in Fig. 3 and in Materials and Meth- 
ods.  This assay is adapted from a standard protocol which 
has been used by other investigators for the analysis of en- 
docytosis of cell surface receptors (Olefsky and K~ao, 1982; 
Prywes et al.,  1986;  Rothenberger et al.,  1987;  Truneh et 
al.,  1983).  In our procedure cells are preincubated at 4°C 
with radioiodinated antibody which  is specific for a given 
class I MHC antigen, washed, and then incubated for vary- 
ing periods of time at 37°C  in the presence or absence of 
PMA.  The culture supernatants are harvested, and then the 
cells are washed in acid to strip cell surface antibody. Culture 
supernatants (which contain any antibody "shed" during the 
37°C incubation), acid washes (containing antibody stripped 
from the cell surface), and cell pellets (having internalized 
antibody molecules) are then counted in a gamma counter. 
We were concerned that our data might be clouded by two 
potential artifacts,  specifically, the unintended  lysis of the 
cells during the acid treatment and insufficient stripping of 
cell surface molecules by this treatment. In control experi- 
ments with 5~Cr-labeled  cells, we have determined that EL4 
cells remain intact during the acid washes, with ~<11% of the 
5~Cr being released from the cells (data not shown). To as- 
sess the efficiency of stripping of cell surface antibody by the 
acid treatment, we examined the amount of ~25I-antibody re- 
maining in the cell pellet when cells are stripped immedi- 
ately after removal of unbound antibody. This control, which 
shows that ~95 % of the radioiodinated antibody which was 
bound by the cells is stripped by the acid treatment, was per- 
formed in all endocytosis studies. 
Internalization of the radioiodinated antibody is dependent 
on metabolism, since cells which are incubated for up to 120 
rain at 4°C in the absence or presence of PMA have equiva- 
lently  low amounts of acid-resistant  radiolabeled antibody 
bound to their surfaces as do control cells which are stripped 
immediately  after  the  4°C  incubation  with  the  antibody 
(Figs.  5, A and B, 6, A-D, and data not shown). 
Incubation  of the  EL4 transfectant  cell  line,  EL~3  with 
PMA at 37°C results in a pronounced increase in the inter- 
nalization of H-2L  d, and has this effect in a dose-dependent 
fashion (Fig. 4).  In an effort to determine the generality of 
this  phenomenon  we  examined  the  internalization  of the 
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Figure 5. Endocytosis of the H-2L  ~ molecule is up-regulated  by PMA in lymphoid cells but not in nonlymphoid cells. BCLi, 18-48,  P815, 
and 27.5.27 Dl cells  (Table I) were incubated  with 5  ×  l0  5 cpm ~251-30.5.7 mAh at 4°C for l  h, washed,  and processed as described in 
Fig.  3 and Materials  and Methods.  Cells  were incubated  at 37°C in the presence (A, zx) or absence (o, o) of 50 ng/ml PMA or at 4°C 
without PMA (m, D) for the time periods indicated after the incubation  with antibody at 4°C (Fig. 3). Open symbols (zx, o, and []) repre- 
sent data for BCL1 (A) and P815 (B), while solid symbols (*, o, and u) represent  27.5.27 DI (A) and 18-48 (B). Each point is the average 
of triplicates,  and each time course was done at least three times for each cell line. The SD of the data used to generate each of the data 
points  is <2% from the value given.  Another H-2LO-L cell transfectant,  27.5.27 FE5, gave essentially  identical  results  (data not shown) 
to those obtained  with 27.5.27 Dl  (A). 
H-2L  ~ antigen in the presence and absence of PMA in the 
cell lines described in Table I. The basal levels and rates of 
endocytosis of H-2L  ~ are comparable in all of the cell lines 
examined (Figs. 5, A and B, and 6 A). However, PMA stimu- 
lation markedly increases the internalization of H-2L  J in B 
(Fig. 5) and T  (Fig. 6) cell lines,  while having no effect on 
P815 mastocytoma cells and L cell fibroblasts (Fig. 5). Kinetic 
analyses  of H-L  d internalization  by these  cell  lines  shows 
that PMA up-regulates the rate of endocytosis of this class I 
MHC antigen in all of the lymphoid cell  lines,  but has no 
effect or even a slightly inhibitory effect on the two nonlym- 
phoid cell lines tested (Fig. 5, A and B).  This phenomenon 
is  not  unique  to  the  transfected  H-2L  ~ antigen,  since  the 
rate  of  internalization  of the  endogenous  H-2D  b class  I 
MHC molecule of EL4 cells is also increased by PMA (Fig. 
6 D). Although the panel of selected cell lines is small, these 
results show that the internalization of class I MHC antigens 
is subject to lineage-specific regulation. 
Internalization  of Class I MHC Antigens Via a 
PMA-inducible Pathway is Abrogated by Alteration 
or Deletion of the Cytoplasmic Domain 
Evidence from a number of cell surface receptor systems es- 
tablishes a role for the cytoplasmic domains of receptors in 
their  endocytosis  via  coated  pits  (Goldstein  eta].,  1985; 
Lehrman et al.,  1985; Davis et al.,  1986,  1987; Iacopetta et 
al.,  1988;  Lazarovits  and  Roth,  1988).  Although  class  I 
MHC antigens have no known role as cell surface receptors, 
they too are internalized via coated pits (Machy et al.,  1987; 
Dasgupta et  al.,  1988).  Having documented the  PMA  in- 
ducibility  of H-2L  ~ internalization  in  lymphoid  cells,  we 
next studied the requirement for the cytoplasmic domain of 
this  molecule in this  process.  We examined an EL4 trans- 
fectant expressing  an  H-2L  ~ antigen  which has  an altered 
cytoplasmic tail  (EIA.907;  Fig.  1)  and  one  expressing  an 
H-2L  ~ molecule which lacks the cytoplasmic tail altogether 
(EL4.2.2.1; Fig.  1) for their ability to internalize these mu- 
Figure 6. H-2L  a antigens  with altered or deleted  cytoplasmic  tails are not endocytosed  in a PMA-inducible  fashion by EL4 transfectants. 
Untransfected  EL4 cells and EI..4 transfectants,  ELa3, EL4.907,  and EL4.2.2.1  (5  ×  10  ~ cells/well  in triplicate)  were incubated  with 5 
x  105 cpm t251-30.5.7 mAb (A, B, and E) or t251-28.14.8 mAb (C, D, and F) at 4°C for 1 h, washed,  and processed as described in Fig. 
3 and Materials  and Methods.  The kinetics  of endocytosis of H-2L  ~ and H-2D  b by these three ceil  lines are shown  in A, B, C, and D. 
Cells were incubated  at 37°C in the presence (A, A) or absence (o, o) of 50 ng/ml PMA or at 4°C without PMA (m, []), for the time 
periods indicated after the incubation  with antibody at 4°C (Fig. 3). In the graphs presented  in A, B, and C, data for ELO3 are represented 
by open symbols (,x, o, and t3). The solid symbols (A,  o, and m) represent  EL4.907 in A and C and EL4.2.2.1  in B and D. In D open 
symbols (,x, o, and D) represent  untransfected  EL4 cells.  Each point is the average of triplicates,  and each time course was done at least 
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three times for each cell line.  The SD of the data used to generate  each of the data points  in graphs  A-D  is ~<2% from the value given, 
except for ELd3 with mAb 28.14.8 at 37°C  +  PMA at  180 min, which is 2.4%  from the value given; EL4.2.2.1  with mAb 28.14.8 at 
37°C  +  PMA at 60 min, which is 2.5%  from the value given; and EL4 with mAb 28.14.8 at 37°C  +  PMA at  180 min, which is 5.1% 
from the value given. The data presented  in E and F are from endocytosis  experiments with ELd3, EL4.907,  and EL4.2.2.1  in which the 
incubation  at 37°C was for 120 min. Data for samples which were incubated at 37°C in the absence of PMA are represented by the stippled 
bars (E and F) and represent the baseline against  which the percent change is measured.  The values obtained for samples which were 
incubated  at 37°C with 50 ng/ml PMA are depicted by the solid bars (E and F) and reflect the percent increase or decrease in endocytosis 
relative to cells not treated  with PMA.  Each bar is the average of triplicates,  and each experiment was done at least twice. The SD of 
the data used to generate  these two graphs  (E and F) is <5 % of the value of the bar, except for EL4.907 with mAb 30.5.7, which is 7.8% 
of the value of the bar; EL4.2.2.1  with mAb 30.5.7, which is 6.7% of the value of the bar; and ELd3 with mAb 28.14.8, which is 7.7% 
of the value of the bar. 
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in Lymphoid and Nonlymphoid Cell Lines 
PMA induction of 
Cell line  Cell type  phosphorylation 
18-48  B  3.5-3.94 
BCL1  B  5.01-5.04 
ELO3  T  6.688-7.26 
P815  Mastocytoma  3.07-4.21 
27.5.27  D-I  Fibroblast  9.00-12.71 
Radiolabeling  of  cells  with  ['S]methionine  and  [nP]orthophosphate,  im- 
munoprecipitation  of H-2L  d glycoproteins,  and  fractionation  of proteins  by 
PAGE,  autoradiography,  and densitometry  were  performed  as described  in 
Materials  and Methods and  in Fig.  7.  Densitometry  was performed  on au- 
toradiograms of the type depicted in Fig. 7 A only. A phosphorylation "index" 
was obtained by measuring the area under the H-2L  a peak relative to the area 
under the ~2-M peak. The effect of PMA on phosphorylation was quantitated 
by dividing the phosphorylation index obtained for PMA-treated cells by that 
obtained  for untreated  cells  under  otherwise  identical conditions.  The  data 
shown represent the range of induction observed in at least two experiments 
for each cell line. 
tant molecules. The tailless 2.2.1  mutant of H-2L  ~ fails to 
be endocytosed in a PMA-inducible fashion, but rather is in- 
ternalized by PMA-treated EL4.2.2.1 cells at the basal rate 
observed in EL4.2.2.1 cells not treated with PMA (Fig. 6, 
B and E). Moreover, its basal level of endocytosis is lower 
than that of the wild-type H-2L  a protein (compare solid and 
open circles, Fig. 6 B). Quite possibly then, the basal level 
of internalization of the 2.2.1 mutant of H-2L  a reflects nor- 
mal membrane turnover rather than selective internalization 
of this H-2 molecule. In this regard, it is noteworthy that the 
2.2.1  mutant has a significantly slower lateral diffusion on 
the cell surface than does the wild-type H-2L  ~ (Jovin, T., 
M. C. Ztifiiga, and M. Edidin, manuscript in preparation). 
In the absence of PMA, the BAL 907 mutant of H-2L  a is 
endocytosed at a rate that is nearly comparable to that of the 
full length molecule (Fig. 6 A), suggesting that the BAL 907 
cytoplasmic domain satisfies some of the structural require- 
ments for the apparently constitutive endocytosis of H-2L  ~ 
that is observed in EL~3 cells.  (Indeed, it is the similarity 
of the basal level of endocytosis of the BAL 907 mutant and 
the wild-type H-2L  a and the contrasting low level observed 
for the 2.2.1 mutant under identical conditions that leads us 
to suggest that there is a constitutive endocytosis of H-2 in 
EIA cells.) That the basal level of endocytosis of the wild- 
type H-2L  a and the BAL 907 mutant are similar is not sur- 
prising, since the lateral diffusion of these two proteins on 
the surfaces of cells not treated with PMA are comparable 
(Edidin and Ztifiiga,  1984). However, like the 2.2.1 mutant, 
the BAL 907 mutant fails to be endocytosed more rapidly in 
PMA-treated  cells  (Fig.  6,  A  and  E).  The failure of the 
EL4.2.2.1 and EL4.907 transfectants to respond to PMA is 
specific for the transfected mutant H-2L  ~ antigens, since the 
endogenous H-2D  b molecule is internalized in a  PMA-in- 
ducible fashion by both of these transfectants (Fig. 6, C, D, and 
F). Hence, the structural motif required for PMA-regulated 
endocytosis by lymphoid cells apparently  resides in or is 
influenced by the cytoplasmic domain of the class I MHC an- 
tigen and is destroyed in the BAL 907 and 2.2.1 mutants of 
H-2L  ~. 
In Vivo Phosphorylation of Class I MHC Antigens 
is Stimulated by Phorbot Esters 
The sequence of events which occurs after mitogenic stimula- 
tion of cells include the accelerated turnover of phospho- 
inositides and the consequent increase in intracellular con- 
centrations of CA  ++ and diacylglycerol (Berridge and Irvine, 
1984). These events trigger protein phosphorylation at ser- 
ine and threonine by protein kinase C  (Nishizuka,  1984). 
Direct activation of protein kinase  C  can be achieved by 
treatment of cells  with  phorbol  esters  (Nishizuka,  1984; 
Rozengurt et al.,  1984).  Since PMA results in increased in- 
ternalization of H-2L  d and  H-2D  b by  lymphoid cells,  we 
reasoned that PMA might also induce the phosphorylation 
of these class  I  MHC  antigens  and  that  phosphorylation 
might be the signal  for internalization.  H-2 antigens were 
immunoprecipitated from lysates of lymphoid and nonlym- 
phoid cells (Table II) which had been labeled with [32p]or- 
thophosphate in the presence or absence of PMA as described 
in Materials and Methods.  The immunoprecipitated poly- 
peptides were analyzed by PAGE and autoradiography. 
To quantitate the phosphorylation of class I MHC antigens 
in different cell types and to measure accurately the effects 
of PMA on in vivo phosphorylation of these proteins, we 
took advantage of the fact that the B:-microglobulin (B2-M) 
light chain which associates noncovalently with the class I 
MHC  antigen  (and  therefore  coimmunoprecipitates  with 
class I  MHC proteins) is not phosphorylated. Since PMA 
has no effect on the amount of [35S]methionine that is incor- 
porated  into  ~/2-M (Fig.  7,  A  and  B;  Capps,  G.  G.,  and 
M.  C.  Ztifiiga,  manuscript in preparation), it is possible to 
use quantitative densitometry (as described in Fig. 7) to mea- 
sure  the  32p-labeled  H-2  protein relative to the  ['S]Bz-M 
present in the same immunoprecipitate. Moreover, it is pos- 
sible to exploit the constancy of [355]~2-M in immunoprecip- 
itates  from cells incubated in the presence and absence of 
PMA to quantitate the 32P-labeled H-2 protein isolated from 
PMA-treated cells to that obtained from untreated cells (refer 
to Fig.  7 for details). 
Phosphorylated forms of the class I MHC molecules occur 
in all of the cell lines examined, regardless of whether or not 
they have been stimulated by PMA (Figs. 7 and 8).  More- 
over, using  the  methods  described above,  we have found 
that H-2L  d molecules are hyperphosphorylated in vivo in 
response to PMA in all cell types examined (Fig. 7, A and 
B,  and  Table II).  The degree of hyperphosphorylation of 
H-2L  d isolated from lymphoid cells is neither notably higher 
nor lower than in H-2L  d isolated from nonlymphoid cells 
(Table II). Thus, while PMA-inducible endocylosis of H-2L  ~ 
is unique to lymphoid cells (among the cell types tested), 
PMA-inducible  hyperphosphorylation of this  molecule is 
not. It should be noted, however, that there are several resi- 
dues which potentially can be phosphorylated (Fig.  1), and 
our current studies do not enable us to exclude the possibility 
that PMA causes hyperphosphorylation of different residues 
in different cell types, with diverse consequences. If this is 
the case, then selective phosphorylation of specific class I 
MHC cytoplasmic domain residues in lymphoid cells may 
target the class I MHC molecule to endocytic vesicles. The 
existence of multiple species of protein kinase C which are 
differentially expressed in lymphoid ceils (Makowske et al., 
1988;  Nishizuka,  1988)  and  of a  lymphoid  cell-specific 
The Journal of Cell Biology, Volume  108, 1989  1324 Figure 7. PMA induces hyperphosphorylation of H-2L  d in lymphoid and nonlymphoid cells.  Approximately 107 cells of the cell lines indi- 
cated were radiolabeled simultaneously with [35S]methionine and [32p]orthophosphate  or with [35S]methionine alone as described in Ma- 
terials and Methods. Samples which were tested for inducibility of phosphorylation by PMA were incubated with 50 ng/ml PMA during 
the last 30 min of the labeling period. Cells were washed and lysed, and H-2 antigens were immunoprecipitated with the 30.5.7 mAb (as 
described in Materials and Methods) and immunoprecipitated proteins were resolved on 15 % SDS-polyacrylamide gels under reducing 
conditions. Samples of'~ 30,000 cpm of immunoprecipitates were loaded per lane. X-ray films were exposed to the dried, Autofluor-treated 
gels under two different conditions.  The autoradiogram shown in A was obtained by placing a piece of paper between the top half of the 
dried gel and the film, effectively preventing the 35S radiation in the top half of the gel from exposing the film (Capps, G. G., and M. C. 
Ztifiiga,  manuscript in preparation).  The autoradiogram in B confirms that this technique  permits selective quantitation  of [32p]H-2Ld 
(H-2) relative to [3sS]/~2-M. Immunoprecipitates in lanes labeled 3~S-met, 32p, and  32p  +  PMA were obtained from cells labeled with 
[35S]methionine alone, [35S]methionine and [32p]orthophosphate  in the absence of PMA, and [35S]methionine and [32p]orthophosphate  in 
the presence of PMA,  respectively. The lane labeled M in B contains '4C-labeled molecular mass markers (carbonic anhydrase, 30 kD; 
ovalbumin, 46 kD; BSA, 69 kD; lactoglobulin A, 18.4 kD; and cytochrome c, 12.3 kD). The two smallest of these proteins are also visible 
in the lane labeled M  in A. 
tyrosine kinase (Veilette et al.,  1988a,b) render this possibil- 
ity particularly  tantalizing. 
Phosphorylation of Class I MHC Antigens Via the 
PMA-inducible Pathway Is Inhibited by Deletion 
or Alteration of the Cytoplasmic Domain 
Previous studies showed that phosphorylation of class I MHC 
antigens  occurs on residues  within the cytoplasmic domain 
(Pober et al.,  1978; Guild and Strominger,  1984; McCluskey 
et al.,  1986).  It is thus not surprising that the 2.2.1  mutant 
of H-2L  d, which has no cytoplasmic tail,  is not phosphory- 
lated in vivo, either in the presence or absence of PMA (Fig. 
8 A).  An entirely different result might have been expected 
for the BAL 907 mutant of H-2L  d, which has several poten- 
tial  sites  for phosphorylation  (four  serines  and  one  threo- 
nine;  see  Fig.  1).  PAGE  and  autoradiographic  analysis  of 
30.5.7  immunoprecipitates  does  in  fact reveal a  phosphor- 
ylated protein with a  mobility that is approximately that of 
the BAL 907  mutant (Fig.  8 A), and perhaps this protein is 
indeed the BAL 907  glycoprotein.  The absence of a  corre- 
sponding band in the immunoprecipitates of EL4.2.2.1  cells 
strengthens  this  argument.  However,  even  if  this  protein 
is the BAL 907  mutant,  its level of phosphorylation  is ex- 
tremely low relative to its wild-type counterpart, and it is not 
significantly  augmented  in PMA-treated  cells  (Fig.  8  A). 
The defective response to PMA is specific for the mutant 
H-2L  d antigens  in  the  EL4.907  and  EL4.2.2.1  cell  lines, 
since  the  endogenous  H-2D  b antigens  of both of these  cell 
lines are phosphorylated in vivo and are hyperphosphorylated 
in response to PMA (Fig.  8 B and Table II). Admittedly, the 
cytoplasmic domain  lesions  in the BAL 907  and 2.2.1  mu- 
tants of the H-2L  d molecule are too gross to permit a corre- 
lation between the lack of cytoplasmic domain phosphoryla- 
tion and PMA-inducible  endocytosis. In fact, only  11  out of 
Capps et al. Phosphorylation and Endocytosis of Class 1 MHC  1325 Figure & H-2L  ~ antigens with altered or deleted cytoplasmic tails are not phosphorylated in vivo in the presence or absence of PMA. Ap- 
proximately  107 ceils  of each transfectant  cell  line  (ELd3, EIA.907, and EL4.2.2.1) were radiolabeled  with  [35Slmethionine or [a2P]or- 
thophosphate  as described in Materials and Methods.  Samples which were tested for inducibility of  phosphorylation by PMA were incubated 
with [3~p]orthophosphate for 2 h before the addition  of 10 ng/ml PMA and further incubation  at 37°C for 30 min. Cells were washed and 
lysed, and H-2 antigens were immunoprecipitated  with either the 30.5.7 mAb (A) or the 28.14.8 mAb (B), and immunoprecipitated  proteins 
were resolved on 15 % SDS-polyacrylamide gels under reducing conditions.  Samples  of ~ 30,000 cpm of 35S-labeled immunoprecipitate 
and ~3,000 cpm of 32p-labeled immunoprecipitate  were loaded per lane.  See Materials  and Methods and Results for further details.  The 
lane labeled  M in A contains  the ~4C-labeled molecular mass markers described in Fig.  7. The mobilities  of the H-2 and/?2-M are indi- 
cated. 
31  amino acids of the wild-type H-2L  d cytoplasmic domain 
occur in the same positions in the BAL 907 cytoplasmic tail. 
Hence, other structural  features necessary for PMA-induc- 
ible endocytosis may be missing from the BAL 907 mutant 
and  from the tailless  mutant as well. 
Discussion 
Selective Nature of  PMA-inducible Endocytosis of 
Cell Surface Proteins 
Phorbol esters have been shown to exert pronounced effects 
on the exocytic and endocytic properties of a number of cell 
surface receptors. Nevertheless, these reagents act selective- 
ly, rather than globally. The most striking evidence on this 
point with regard to MHC antigens is the fact that EIA.907 
and EL4.2.2.1  transfectants fail to endocytose mutant H-2L  d 
antigens in a PMA-inducible fashion, while the H-2D  b anti- 
gens  of these  cells  are  internalized  more efficiently  in the 
presence of PMA. Clearly, the endocytosis-defective H-2L  d 
mutants  are  not  carried  into  the  cell  in  a  wave of PMA- 
induced  clustering  of cell  surface  molecules  to  endocytic 
invaginations of the plasma membrane.  Thus,  while  PMA 
may affect membrane trafficking in general (McGraw et al., 
1988),  not all  cell  surface molecules  are  mobilized  in re- 
sponse to PMA. Equally striking is the cell specificity of the 
effect of PMA on class [ MHC antigen internalization.  Nei- 
ther the P815 mastocytoma nor the L cell fibroblasts internal- 
ize H-2L  d in response to PMA, although they undergo mor- 
phological changes when exposed to this  reagent  (Ztifiiga, 
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vations). Hence, the internalization of class I MHC antigens 
by lymphoid cells in response to PMA may reflect a unique 
function of these molecules in lymphoid cells (see below). 
It has been reported previously that at least some of the 
class I  MHC antigens which are internalized by mitogen- 
activated T lymphocytes are endocytosed via clathrin-coated 
vesicles (Machy et al.,  1987). More recently, class I MHC 
antigen endocytosis in monocytes also has been shown to 
occur via clathrin-coated vesicles (Dasgupta et al.,  1988). 
Phorbol esters were not used in either of these studies. Ongo- 
ing studies in our laboratory are directed at ascertaining if 
the class I  MHC antigen endocytosis which occurs in re- 
sponse to PMA  involves clathrin-coated pits and clathrin- 
coated vesicles. We also will determine if the endocytosis of 
the PMA-refractory BAL 907 mutant occurs via noncoated 
vesicles as has been demonstrated for class I MHC antigen 
endocytosis in fibroblasts (Huet et al., 1980), or if it is inter- 
nalized via clathrin-coated pits in spite of the alterations in 
its cytoplasmic tail. 
A related issue which interests us is the fate of  class I MHC 
antigens which are internalized via the PMA-regulated path- 
way. Does their intracellular destination differ from that of 
class  I  MHC  molecules  which  are  endocytosed by  cells 
which have not been treated with PMA? We are conducting 
electron microscopic studies to determine the fates of class 
I MHC antigens which enter the cell by these two apparently 
distinct pathways. 
Is Phosphorylation the Signal  for PMA-inducible 
Endocytosis? 
The occurrence of PMA-induced hyperphosphorylation of 
the cytoplasmic domain of the H-2L  ~ molecule in nonlym- 
phoid as well as lymphoid cells can be interpreted as evi- 
dence to discount this modification of the class I MHC an- 
tigen as a  required signal  for PMA-inducible endocytosis. 
Studies on other cell surface receptors have failed to establish 
a correlation between cytoplasmic domain phosphorylation 
and endocytosis. For example, modification of cytoplasmic 
serine residues of the transferrin receptor, while preventing 
phosphorylation, does not affect endocytosis (Rothenberger 
et al., 1987; Zerial et al., 1987; McGraw et ai., 1988). How- 
ever, phosphoamino acid and phosphopeptide analyses must 
be performed to exclude the possibility that different phos- 
phorylation events are triggered in different cell types which 
potentially play a role in lymphoid-specific internalization of 
class I MHC antigens. 
Another question bearing on this issue is whether a partic- 
ular secondary or tertiary structure (which is lacking in the 
BAL 907 mutant of H-2L  d) provides the signal  for PMA- 
inducible endocytosis, or if the signal is comprised of the pri- 
mary structure of one or a few amino acids, as has recently 
been reported for other proteins (Davis et al.,  1986,  1987; 
Lazarovits and Roth, 1988). These studies indicate that a sin- 
gle tyrosine in the cytoplasmic domain is required for en- 
docytosis via coated pits. These reports are of interest here, 
since the  cytoplasmic domain of the  BAL 907  mutant of 
H-2L  d lacks a tyrosine (Fig.  1) which is conserved among 
class  I  MHC  antigens  of several  species  (summarized  in 
McCluskey et al.,  1986). We are selectively changing single 
amino acid residues within the cytoplasmic domain of the 
H-2L  ~ antigen to identify the structural features on the cyto- 
plasmic domain which are required for endocytosis of the 
class I MHC antigen and to determine the relationship be- 
tween PMA-inducible phosphorylation and PMA-regulated 
endocytosis. 
Potential Structural Features Necessary  for 
PMA-inducible Phosphorylation 
The studies described herein show that substitution of the 
wild-type 31  amino acid cytoplasmic domain of the H-2L  ~ 
antigen with a dissimilar 25 amino acid tail renders the pro- 
tein refractory to in vivo phosphorylation. The cytoplasmic 
tail of the BAL 907 mutant of H-2L  d contains several resi- 
dues which are potential sites for phosphorylation (Fig.  1), 
yet this molecule is a  poor substrate for phosphorylation, 
even in PMA-treated cells (Fig. 8 A). It has been previously 
noted by McCluskey and co-workers that the cytoplasmic do- 
main sequence Ser-Asp/Glu-X-Ser-Leu is conserved among 
the class I MHC antigens of mouse, human, pig, and rabbit 
(McCluskey et al.,  1986). The second serine in this sequence 
(serine 335) is phosphorylated in human class I MHC anti- 
gens (Pober et al.,  1978; Guild et al.,  1984). In all human 
and mouse class I molecules the cluster is preceded by a ser- 
ine or a threonine, so that the sequence which is conserved 
among these class I MHC glycoproteins reads Ser/Thr-Ser- 
Asp/Glu-X-Ser-Leu. The sequence in the corresponding re- 
gion of BAL 907 reads Ser-Pro-Arg-Ile-Ser, with the protein 
terminating with the second serine (Fig. 1). The most notable 
differences between BAL 907 and other class I molecules in 
this region are the substitution of the proline for the second 
serine and the substitution of the basic arginine for the acidic 
residue found in other molecules. Clearly, further mutagene- 
sis analysis is necessary to determine the structural features 
necessary for phosphorylation of the class I MHC antigen 
cytoplasmic domain.  Nevertheless, these observations, to- 
gether with the lack of a striking consensus sequence for sub- 
strates of protein kinase C or cAMP-dependent protein ki- 
nase A, suggest that a suitable substrate for these enzymes 
is provided, not by a specific sequence, but rather by a partic- 
ular protein conformation which is attained by polypeptides 
via intra- or intermolecular interactions. Although in vivo in- 
teractions between the cytoplasmic domains of class I MHC 
antigens  and other cellular proteins are yet to be demon- 
strated, class I MHC antigens have been shown to interact 
with cytoskeletal proteins in vitro, presumably via contact 
sites on the cytoplasmic domain of the class I MHC molecule 
(Pober et al.,  1981). 
Possible Significance of  PMA-inducible 
Phosphorylation and Endocytosis of 
Class I MHC Molecules 
The only well documented role of class I MHC molecules 
is in presenting foreign antigen to T lymphocytes, yet a num- 
ber of studies have implicated these molecules in other im- 
munological and nonimmunological functions. Of particular 
interest is the evidence for a regulatory role of class I MHC 
molecules in T lymphocyte and B lymphocyte activation; an- 
tibodies to class I MHC antigens block allogeneic and virus- 
specific T cell responses (Sterkers et al.,  1983) and inhibit 
the activation and proliferation of human T lymphocytes in- 
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et al.,  1986; Dasgupta et al.,  1987; De Felice et al.,  1987; 
Huet et al.,  1987). Interestingly, antibodies to class I MHC 
antigens enhance proliferation via the CD2 molecule, a path- 
way of T cell activation thought to operate in mature T cells 
as well as in immature thymocytes which lack a functional 
CD3-T  cell  receptor complex  (Turco et al.,  1988).  These 
and other studies have led to the suggestion that anti-class I 
MHC antibodies modulate an early event in T cell activation 
(Turco et al.,  1988).  Similarly, antibodies to class I MHC 
antigens inhibit the proliferation of human B cells to T-inde- 
pendent mitogens, but have no effect on PMA-induced prolif- 
eration (Taylor et al.,  1987). These latter  results have been 
interpreted to indicate that class I MHC molecules regulate 
a critical event in B cell proliferation which precedes the up- 
regulation of protein kinase C activity. Even if class I MHC 
molecules do influence or regulate early events in lympho- 
cyte proliferation, the role of their endocytosis in this func- 
tion is a matter of speculation. One favored hypothesis is that 
these proteins associate with molecules known to be impor- 
tant in cell growth, such as the insulin receptor, and are inter- 
nalized with them (Samson et al.,  1986). 
While it is not clear if the phosphorylation of class I MHC 
antigens is related mechanistically to their endocytosis, it is 
almost certainly related to activation of lymphocytes. Stimu- 
lation of proliferation of lymphocytes by mitogens and anti- 
gens has been shown to involve signal transduction via pro- 
tein kinase C (Farrar and Ruscetti, 1986; Imboden and Stobo, 
1985; Coggeshall and Cambier,  1984). Hence, the enhanced 
phosphorylation and endocytosis of class I MHC antigens in 
PMA-treated lymphoid cell lines may reflect a normal phys- 
iological process which occurs in response to certain mito- 
gens or other activators.  Other studies from our laboratory 
show  that PMA-inducible  endocytosis occurs  in  a  cloned 
cytotoxic  T  cell  line  and  in  normal  spleen  cells  (Capps, 
G.  G., M. Van Kampen, C. L. Ward, and M. C. Ztifiiga,  un- 
published observations). 
Although the functional significance of the inducibility of 
phosphorylation and endocytosis of class I MHC antigens by 
PMA  is yet to be demonstrated,  the observations reported 
herein demonstrate that the cell surface expression of these 
molecules is regulated in a manner similar to that observed 
to operate on other cell surface molecules implicated in sig- 
nal transduction during activation of lymphoid cells. Further 
studies with antigen-specific T cell and B cell lines should 
make it possible to elucidate the functional relevance of the 
phosphorylation and endocytosis of class I MHC antigens in 
lymphocytes. 
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